TruBridge, Inc. (NASDAQ: TBRG) is a company that provides business, consulting, and IT services. It operates in the healthcare information technology sector. The company has a market capitalization, which is the total value of all its shares, of approximately $318.49 million. Its stock currently trades at $21.22 per share.
On April 13, 2026, the analyst firm Jefferies upgraded its rating on TruBridge to a "Hold." A hold rating suggests that investors should keep their current position in the stock, not buying more or selling. The stock price at the time of this rating change was $21.22, reflecting a single-day gain of 18.02%.
This upgrade comes amid legal challenges. As highlighted by GlobeNewswire, the Rosen Law Firm is investigating TruBridge for allegedly providing misleading business information. The firm is preparing a class-action lawsuit, which is a legal action filed on behalf of a group, to recover shareholder losses.
The investigation follows TruBridge's failure to file its Annual Report on time, which was noted on March 17, 2026. This delay and the subsequent allegations from the law firm introduce a level of risk and uncertainty for investors considering the company's stock.
However, an analysis by Zacks Investment Research suggests investors may be undervaluing TruBridge. This view is based on a system that focuses on earnings estimates and revisions to find strong stocks. The stock's price has moved between $19.27 and $22.12 during the day, with a 52-week high of $26.74 and low of $13.88.
